Vinorelbine

Sold as Navelbine, Vinelba, Vinorelbin "ebewe", Vinorel, Aspen vinorelbin, Cipla-vinorelbine, Sandoz vinorelbine, Navilin, Nivocha, Vinorelbine accord

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 9
Registrations: 21
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Tema Medical (Pty) LtdCancelled	Navelbine, Vinelba	40 mg, 50, 80 mg	360014, 360015, 370360	S4	None
Key Oncologics (Pty) LtdCancelled	Vinorelbin "ebewe"	10 mg, 50 mg	410413, 410414	S4	None
Pharmaplan (Pty) LtdCancelled	Vinorel	10, 50	410834, 420005	S4	None
Pharmacare limited û woodmead	Aspen vinorelbin	10 mg/1 ml, 50 mg/5 ml	420020, 420021	S4	None
Cipla Medpro (Pty) LtdCancelled	Cipla-vinorelbine	10, 50	420083, 420084	S4	None
Sandoz South Africa (Pty) Ltd	Sandoz vinorelbine	10 mg/1 ml, 50 mg/5 ml	420132, 420133	S4	None
Eurolab (Pty) Ltd	Navilin	20, 30	530743, 530744	S4	PI PIL
Encha Health (Pty) Ltd	Nivocha	20 mg, 30 mg, 80 mg	570397, 570398, 570399	S4	None
Accord Healthcare (Pty) Ltd	Vinorelbine accord	20 mg, 30 mg, 80 mg	570810, 570811, 570812	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Navelbine oral 40 MG EACH CAPSULE CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 40,0 mg	40 mgOral	36001436/26/0014	Cancelled	S4	None
Navelbine oral 80 MG EACH CAPSULE CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 80,0 mg	80 mgOral	36001536/26/0015	Cancelled	S4	None
Vinelba 50 EACH 5,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 50,0 mg	50	37036037/26/0360	Cancelled	S4	None
Vinorelbin "ebewe" 10 MG EACH 1,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 10,0 mg	10 mg	41041341/26/0413	Cancelled	S4	None
Vinorelbin "ebewe" 50 MG EACH 5,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 50,0 mg	50 mg	41041441/26/0414	Cancelled	S4	None
Vinorel 10 EACH VIAL CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 10,0 mg	10	41083441/26/0834	Cancelled	S4	None
Vinorel 50 EACH VIAL CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 50,0 mg	50	42000542/26/0005	Cancelled	S4	None
Aspen vinorelbin 10 mg/1 ML EACH 1,0 ml VIAL CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 10,0 mg	10 mg/1 ml	42002042/26/0020	Registered	S4	None
Aspen vinorelbin 50 mg/5 ML EACH 5,0 ml VIAL CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 50,0 mg	50 mg/5 ml	42002142/26/0021	Registered	S4	None
Cipla-vinorelbine 10 EACH 1,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 10,0 mg	10	42008342/26/0083	Cancelled	S4	None
Cipla-vinorelbine 50 EACH 5,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 50,0 mg	50	42008442/26/0084	Cancelled	S4	None
Sandoz vinorelbine 10 mg/1 ML EACH 1,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 10,0 mg	10 mg/1 ml	42013242/26/0132	Registered	S4	None
Sandoz vinorelbine 50 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 50,0 mg	50 mg/5 ml	42013342/26/0133	Registered	S4	None
Navilin 20 ECAPSULE CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 20,0 mg	20Capsule	53074353/26/0743Approved 8 June 2021	Registered	S4	PI PIL
Navilin 30 ECAPSULE CONTAINS VINORELBINE TARTRATE EQUIVALENT TO VINORELBINE 30,0 mg	30Capsule	53074453/26/0744Approved 8 June 2021	Registered	S4	PI PIL
Nivocha 20 MG Each Capsule contains: Vinorelbine equivalent to vinorelbine 20,0 mg	20 mg	57039757/26/0397	Registered	S4	None
Nivocha 30 MG Each Capsule contains: Vinorelbine equivalent to vinorelbine 30,0 mg	30 mg	570398	Registered	S4	None
Nivocha 80 MG Each Capsule contains; Vinorelbine Tartrate equivalent to vinorelbine 80,0 mg	80 mg	57039957/26/0399	Registered	S4	None
Vinorelbine 20 MG accord Each Capsule contains: Vinorelbine equivalent to vinorelbine 20,0 mg	20 mg	57081057/26/0810	Registered	S4	None
Vinorelbine 30 MG accord Each Capsule contains: Vinorelbine equivalent to vinorelbine 30,0 mg	30 mg	57081157/26/0811	Registered	S4	None
Vinorelbine 80 MG accord Each capsule contains: Vinorelbine Tartrate equivalent to Vinorelbine 80,0 mg	80 mg	57081257/26/0812	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Vinorelbine tartrate equivalent to vinorelbine

S4: Vinorelbine
Consolidated Schedules 06 July 2026, line 8384

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsNavilin 20, Eurolab (Pty) Ltd Patient information leaflet (PIL)For patients and carersNavilin 20, Eurolab (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background